Mechanisms contributing to cardiac remodelling.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical science

• Publication date

  2017-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/CS20171167PMID 28842527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets

  2018cited by this paper
• Role of Endoplasmic Reticulum Stress, Autophagy, and Inflammation in Cardiovascular Disease

  2017cited by this paper
• Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure.

  2017cited by this paper
• Harnessing the early post-injury inflammatory responses for cardiac regeneration

  2017cited by this paper
• A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition

  2017cited by this paper
• 5922A novel APJ ligand, ELABELA/Apela/Toddler, protects from pressure overload- and Angiotensin II-induced cardiac hypertrophy and fibrosis

  2017cited by this paper
• Corrigendum: Toll-like receptor-2 has a critical role in periodontal pathogen-induced myocardial fibrosis in the pressure-overloaded murine hearts

  2017cited by this paper
• The role of cardiac energy metabolism in cardiac hypertrophy and failure

  2017cited by this paper
• Toll-like receptor-2 has a critical role in periodontal pathogen-induced myocardial fibrosis in the pressure-overloaded murine hearts

  2017cited by this paper
• Angiotensin Receptor–Neprilysin Inhibition

  2017cited by this paper
• Autophagy during cardiac remodeling.

  2016cited by this paper
• Physiological and pathological cardiac hypertrophy.

  2016cited by this paper
• Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways

  2016cited by this paper
• Pregnancy mitigates cardiac pathology in a mouse model of left ventricular pressure overload.

  2016cited by this paper
• Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway

  2016cited by this paper
• A Modern Definition of the Athlete's Heart-for Research and the Clinic.

  2016cited by this paper
• Extracellular matrix-mediated cellular communication in the heart.

  2016cited by this paper
• Positive Role for a Negative Calcineurin Regulator in Cardiac Hypertrophy.

  2016cited by this paper
• Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases

  2016cited by this paper
• Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases

  2016cited by this paper
• The emerging role of Toll-like receptor 4 in myocardial inflammation

  2016cited by this paper
• Cardiac Fibrosis: The Fibroblast Awakens.

  2016cited by this paper
• Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs).

  2016cited by this paper
• Molecular Aspects of Exercise-induced Cardiac Remodeling.

  2016cited by this paper
• Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction

  2016cited by this paper
• Rescue of Pressure Overload‐Induced Heart Failure by Estrogen Therapy

  2016cited by this paper
• The role of AMPK in cardiomyocyte health and survival.

  2016cited by this paper
• mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy

  2016cited by this paper
• Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation.

  2016cited by this paper
• Protection against cardiac hypertrophy by geniposide involves the GLP‐1 receptor / AMPKα signalling pathway

  2016cited by this paper
• The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin‐II‐Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4

  2016cited by this paper
• NOD2 contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation.

  2016cited by this paper
• Mnk1 (Mitogen-Activated Protein Kinase–Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice

  2016cited by this paper
• Signaling pathways involved in cardiac energy metabolism

  2016cited by this paper
• OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells.

  2016cited by this paper
• C/EBPβ is required in pregnancy-induced cardiac hypertrophy.

  2016cited by this paper
• Endothelial Plasticity: Shifting Phenotypes through Force Feedback

  2016cited by this paper
• How cardiomyocytes sense pathophysiological stresses for cardiac remodeling

  2016cited by this paper
• Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy

  2016cited by this paper
• The cardiac enigma: current conundrums in heart failure research

  2016cited by this paper
• Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

  2015cited by this paper
• NOD1, a new player in cardiac function and calcium handling.

  2015cited by this paper
• Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.

  2015cited by this paper
• Functions of Autophagy in Pathological Cardiac Hypertrophy

  2015cited by this paper
• Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart

  2015cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.

  2015cited by this paper
• MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.

  2015cited by this paper
• Getting to the heart of the matter: new insights into cardiac fibrosis.

  2015cited by this paper
• Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.

  2015cited by this paper
• Basic mechanisms in endoplasmic reticulum stress and relation to cardiovascular diseases.

  2015cited by this paper
• MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo

  2015cited by this paper
• DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.

  2015cited by this paper
• Naringenin attenuates pressure overload-induced cardiac hypertrophy.

  2015cited by this paper
• Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.

  2015cited by this paper
• Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

  2015cited by this paper
• Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease

  2015cited by this paper
• MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo

  2015cited by this paper
• Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.

  2015cited by this paper
• Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure.

  2015cited by this paper
• Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα

  2015cited by this paper
• Icariin protects H9c2 cardiomyocytes from lipopolysaccharide‑induced injury via inhibition of the reactive oxygen species‑dependent c‑Jun N‑terminal kinases/nuclear factor-κB pathway.

  2015cited by this paper
• Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

  2015cited by this paper
• The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

  2015cited by this paper
• Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition.

  2015cited by this paper
• 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.

  2015cited by this paper
• Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.

  2015cited by this paper
• Ongoing controversies surrounding cardiac remodeling: is it black and white—or rather fifty shades of gray?

  2015cited by this paper
• New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction

  2014cited by this paper
• Angiotensin-neprilysin inhibition versus enalapril in heart failure.

  2014cited by this paper
• Carabin Protects Against Cardiac Hypertrophy by Blocking Calcineurin, Ras, and Ca2+/Calmodulin-Dependent Protein Kinase II Signaling

  2014cited by this paper
• Cardiac CaM Kinase II Genes &dgr; and &ggr; Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy

  2014cited by this paper
• Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension.

  2014cited by this paper
• Endoplasmic Reticulum Stress Sensor Protein Kinase R–Like Endoplasmic Reticulum Kinase (PERK) Protects Against Pressure Overload–Induced Heart Failure and Lung Remodeling

  2014cited by this paper
• "Triple therapy" of heart failure with angiotensin-converting enzyme inhibitor, beta-blocker, and aldosterone antagonist may triple survival time: shouldn't we tell patients?

  2014cited by this paper
• Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes.

  2014cited by this paper
• Fibroblast-mediated pathways in cardiac hypertrophy.

  2014cited by this paper
• Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.

  2014cited by this paper
• Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor

  2014cited by this paper
• Casein kinase 1 regulates Sprouty2 in FGF–ERK signaling

  2014cited by this paper
• NOD1 receptor is up-regulated in diabetic human and murine myocardium.

  2014cited by this paper
• Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

  2014cited by this paper
• Mnk kinase pathway: Cellular functions and biological outcomes.

  2014cited by this paper
• PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.

  2014cited by this paper
• Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication

  2014cited by this paper
• Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase &agr;2

  2014cited by this paper
• Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways

  2014cited by this paper
• Innate immune receptors in heart failure: Side effect or potential therapeutic target?

  2014cited by this paper
• CD4+ T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload

  2014cited by this paper
• Cdk1, PKCδ and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death.

  2014cited by this paper
• Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology.

  2014cited by this paper
• The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway

  2014cited by this paper
• Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species: Consequences and therapeutic strategies in the heart.

  2013cited by this paper
• Energy Metabolism in Cardiac Remodeling and Heart Failure

  2013cited by this paper
• Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.

  2013cited by this paper
• Oxidative stress and transforming growth factor-β1-induced cardiac fibrosis.

  2013cited by this paper
• CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.

  2013cited by this paper
• Cathepsin‐L Ameliorates Cardiac Hypertrophy Through Activation of the Autophagy–Lysosomal Dependent Protein Processing Pathways

  2013cited by this paper
• Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase

  2013cited by this paper
• New directions in ER stress-induced cell death

  2013cited by this paper
• NOD2 Deficiency Protects against Cardiac Remodeling after Myocardial Infarction in Mice

  2013cited by this paper

• Protosappanin A protects against pathological cardiac hypertrophy by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis via activation of the Nrf2 signaling pathway

  2026cites this paper
• Consequences of Right Heart Disease for Cardiac Electrophysiology and Arrhythmias: Cellular and Structural Mechanisms

  2025cites this paper
• Stem Cell Therapy in Ischemic Heart Failure

  2025cites this paper
• Evaluating the effects of coffee consumption on the structure and function of the heart from multiple perspectives

  2025cites this paper
• Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

  2025cites this paper
• Lentinan alleviates angiotensin II-induced myocardial remodeling through LMP7-SOCS3 signaling.

  2025cites this paper
• CELF1 Promotes Post-myocardial Infarction Cardiac Remodeling Via Suppression of FMO2

  2025cites this paper
• Baicalin Prevents Chronic β‐AR Agonist‐Induced Heart Failure via Preventing Oxidative Stress and Overactivation of the NADPH Oxidase NOX2

  2025cites this paper
• HACE1 protects against myocardial ischemia–reperfusion injury via inhibition of mitochondrial fission in mice

  2025cites this paper
• Astragali Radix-Notoginseng Radix et Rhizoma medicine pair prevents cardiac remodeling by improving mitochondrial dynamic balance.

  2025cites this paper
• Bi-ventricular elastic material parameters estimation using 3D CMR myocardial strains in rheumatic heart disease patients.

  2025cites this paper
• Explainable AI associates ECG aging effects with increased cardiovascular risk in a longitudinal population study

  2025cites this paper
• Effects of conventional yogurt, probiotic-enriched yogurt, and isolated probiotic on bone and heart parameters in a chronic kidney disease experimental model

  2025cites this paper
• Sexually dimorphic effects of in-utero exposure to a real-life environmental chemical mixture on markers of cardiovascular function in adult sheep.

  2025cites this paper
• LARP1 acts as a key mediator in preventing angiotensin II-induced cardiac dysfunction and fibrosis

  2025cites this paper
• The Roles of Flavonoids and Other Plant‐Based Phenolics in Mitigating Diabetes‐Induced Macrovascular Complications

  2025cites this paper
• Predictors of long-term adverse course in acute myocarditis: a multicenter cohort study.

  2025cites this paper
• Extrarenal benefits of SGLT2 inhibitors in the treatment of cardiomyopathy.

  2024cites this paper
• Construction of a Near-Infrared Fluorescent Probe for Dynamic Monitoring and Early Diagnosis of Heart Failure.

  2024cites this paper
• Zhen-wu-tang protects against myocardial fibrosis by inhibiting M1 macrophage polarization via the TLR4/NF-κB pathway.

  2024cites this paper
• Baicalin alleviates angiotensin II‐induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway

  2024cites this paper
• Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors.

  2024cites this paper
• Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)

  2024cites this paper
• Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice

  2024cites this paper
• Sirtuin 1 mediates the pro-survival effects of vitamin D in angiotensin II-induced hypertrophy of H9c2 cardiomyoblasts

  2024cites this paper
• 4-Hydroxychalcone attenuates AngII-induced cardiac remodeling and dysfunction via regulating PI3K/AKT pathway

  2024cites this paper
• A multi-omics approach identifies the key role of disorders of sphingolipid metabolism in Ang II-induced hypertensive cardiomyopathy myocardial remodeling

  2024cites this paper
• Myoferlin alleviates pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting NLRP3-mediated pyroptosis

  2024cites this paper
• Role of autophagy in myocardial remodeling after myocardial infarction.

  2024cites this paper
• Neuregulin-4 alleviates isoproterenol (ISO)-induced cardial remodeling by inhibiting inflammation and apoptosis via AMPK/NF-κB pathway.

  2024cites this paper
• Noncoding RNA network crosstalk in organ fibrosis.

  2024cites this paper
• Postnatally overfed mice display cardiac function alteration following myocardial infarction.

  2024cites this paper
• The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”

  2024cites this paper
• Bioderived Nanoparticles for Cardiac Repair.

  2024cites this paper
• Progress in the Treatment of Pathological Cardiac Remodeling with Sodium-Glucose Cotransporter 2 Inhibitors

  2024cites this paper
• Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases

  2024cites this paper
• Epikardiales Fett: kardiovaskuläre Risiken und Manifestation einer veränderten Fettverteilung

  2024cites this paper
• Recent advances of PIWI‐interacting RNA in cardiovascular diseases

  2024influential citation
• U shape association between triglyceride glucose index and congestive heart failure in patients with diabetes and prediabetes

  2024cites this paper
• USP38 exacerbates pressure overload-induced left ventricular electrical remodeling

  2024cites this paper
• MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway.

  2024cites this paper
• Stretch-Induced Compliance mechanism in pregnancy-induced cardiac hypertrophy and the impact of cardiovascular risk factors.

  2024cites this paper
• Association of Paraoxonase-1 and NT-proBNP with Clinical, Clinico-Pathologic and Echocardiographic Variables in Dogs with Mitral Valve Disease

  2023cites this paper
• IL-27 promotes cardiac fibroblast activation and aggravates cardiac remodeling post myocardial infarction

  2023cites this paper
• COX6A2 deficiency leads to cardiac remodeling in human pluripotent stem cell-derived cardiomyocytes

  2023cites this paper
• Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression

  2023cites this paper
• Semaphorin‑3A alleviates cardiac hypertrophy by regulating autophagy

  2023cites this paper
• miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway

  2023cites this paper
• Altered ventricular longitudinal strain in children with sickle cell disease: Role of TGF‐β and IL‐18

  2023cites this paper
• The Role of Ranolazine in Heart Failure-Current Concepts.

  2023cites this paper
• Liraglutide Suppresses Myocardial Fibrosis Progression by Inhibiting the Smad Signaling Pathway

  2023cites this paper
• Hepatic Hemodynamics in Chronic Heart Failure of Ischemic Genesis

  2023cites this paper
• [Inhibitor of growth protein-2 silencing alleviates angiotensin Ⅱ-induced cardiac remodeling in mice by reducing p53 acetylation].

  2023cites this paper
• Cardiovascular risk factors during pregnancy impact the postpartum cardiac and vascular reverse remodeling.

  2023cites this paper
• PiRNA in Cardiovascular Disease: Focus on Cardiac Remodeling and Cardiac Protection

  2023cites this paper
• FUNDC1: An Emerging Mitochondrial and MAMs Protein for Mitochondrial Quality Control in Heart Diseases

  2023cites this paper
• Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy.

  2023cites this paper
• Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis.

  2023cites this paper
• Ginsenoside Rb1 promotes the activation of PPARα pathway via inhibiting FADD to ameliorate heart failure.

  2023cites this paper
• MiR-133a/CD47 axis is a novel prognostic biomarker to promote triple negative breast cancer progression.

  2023cites this paper
• Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging

  2023cites this paper
• The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy

  2023cites this paper
• Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments

  2023cites this paper
• The major factor of left ventricular systolic dysfunction in patients with cardiac amyloidosis: Amyloid overload or microcirculation impairment?

  2023cites this paper
• Inhibition of Long Noncoding RNA Gm41724 Alleviates Pressure Overload-induced Cardiac Fibrosis by Regulating Lamin-Associated Polypeptide 2α.

  2023cites this paper
• Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats

  2023cites this paper
• Myosin light-chain 4 gene-transfer attenuates atrial fibrosis while correcting autophagic flux dysregulation

  2023cites this paper
• Left Ventricular Hypertrophy in Male and Female Judo Athletes

  2023cites this paper
• Low-Volume and High-Intensity Aerobic Interval Training May Attenuate Dysfunctional Ventricular Remodeling after Myocardial Infarction: Data from the INTERFARCT Study

  2023cites this paper
• Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages

  2022cites this paper
• New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease

  2022cites this paper
• Lingguizhugan decoction dynamically regulates MAPKs and AKT signaling pathways to retrogress the pathological progression of cardiac hypertrophy to heart failure.

  2022cites this paper
• Melatonin protected against myocardial infarction injury in rats through a Sirt6-dependent antioxidant pathway.

  2022cites this paper
• Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling

  2022cites this paper
• LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.

  2022cites this paper
• Predictors of permanent pacemaker insertion after mitral valve replacement: A systematic review

  2022cites this paper
• Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization.

  2022cites this paper
• B lymphocytes subpopulations are associated with cardiac remodeling in elderly patients with advanced chronic kidney disease.

  2022cites this paper
• Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway

  2022cites this paper
• Sulfasalazine exacerbates angiotensin II‐induced cardiac remodelling by activating Akt signal pathway

  2022cites this paper
• Human Cardiac Progenitor Cell-Derived Extracellular Vesicles Exhibit Promising Potential for Supporting Cardiac Repair in Vitro

  2022cites this paper
• A comprehensive review of cycloastragenol: biological activity, mechanism of action and structural modifications

  2022cites this paper
• Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution

  2022cites this paper
• Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

  2022cites this paper
• Knockdown of HDAC6 alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy

  2022cites this paper
• Sensitivity of ventricular systolic function to afterload during veno‐arterial extracorporeal membrane oxygenation

  2022cites this paper
• Cardiac Remodelling Following Cancer Therapy: A Review

  2022cites this paper
• Increased inflammatory markers in adult patients born with an atrial septal defect

  2022cites this paper
• Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis

  2022cites this paper
• Inhibitory effect of (pro)renin receptor decoy inhibitor PRO20 on endoplasmic reticulum stress during cardiac remodeling

  2022cites this paper
• Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fraction

  2022cites this paper
• Role of resveratrol in inhibiting pathological cardiac remodeling

  2022cites this paper
• Fathoming the role of mTOR in diabetes mellitus and its complications.

  2022cites this paper
• Reversibility of adverse cardiac remodeling in type 2 diabetes mellitus patients: focus on sodium-glucose cotransporter-2 inhibitors

  2022cites this paper
• Research Progress on N6-adenosylate Methylation RNA Modification in Heart Failure Remodeling

  2022cites this paper
• Blocking VCAM-1 ameliorates hypertensive cardiac remodeling by impeding macrophage infiltration

  2022cites this paper
• Natural sea salt in diet ameliorates better protection compared to table salt in the doxorubicin-induced cardiac remodeling

  2022cites this paper
• Serum Vitamin D Levels, Disease Activity Score-28 for Rheumatoid Arthritis with C-Reactive Protein (DAS28-CRP), and Cardiac Remodeling Determined by Ventricular Dimensions and Left Atrium Diameter in Patients with Rheumatoid Arthritis: A Prospective Observational Study

  2022cites this paper
• MOTS-c and aerobic exercise induce cardiac physiological adaptation via NRG1/ErbB4/CEBPβ modification in rats.

  2022cites this paper
• Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy

  2021cites this paper